دورية أكاديمية

Vaccines against gastroenteritis, current progress and challenges

التفاصيل البيبلوغرافية
العنوان: Vaccines against gastroenteritis, current progress and challenges
المؤلفون: Hyesuk Seo, Qiangde Duan, Weiping Zhang
المصدر: Gut Microbes, Vol 11, Iss 6, Pp 1486-1517 (2020)
بيانات النشر: Taylor & Francis Group, 2020.
سنة النشر: 2020
المجموعة: LCC:Diseases of the digestive system. Gastroenterology
مصطلحات موضوعية: enteric diseases, vaccinology, multiepitope fusion antigen (mefa), enterotoxigenic escherichia coli (etec), vibrio cholerae, shigella, nontyphoidal salmonella, campylobacter, rotavirus, norovirus, Diseases of the digestive system. Gastroenterology, RC799-869
الوصف: Enteric viral and bacterial infections continue to be a leading cause of mortality and morbidity in young children in low-income and middle-income countries, the elderly, and immunocompromised individuals. Vaccines are considered an effective and practical preventive approach against the predominantly fecal-to-oral transmitted gastroenteritis particularly in the resource-limited countries or regions where implementation of sanitation systems and supply of safe drinking water are not quickly achievable. While vaccines are available for a few enteric pathogens including rotavirus and cholera, there are no vaccines licensed for many other enteric viral and bacterial pathogens. Challenges in enteric vaccine development include immunological heterogeneity among pathogen strains or isolates, a lack of animal challenge models to evaluate vaccine candidacy, undefined host immune correlates to protection, and a low protective efficacy among young children in endemic regions. In this article, we briefly updated the progress and challenges in vaccines and vaccine development for the leading enteric viral and bacterial pathogens including rotavirus, human calicivirus, Shigella, enterotoxigenic Escherichia coli (ETEC), cholera, nontyphoidal Salmonella, and Campylobacter, and introduced a novel epitope- and structure-based vaccinology platform known as MEFA (multiepitope fusion antigen) and the application of MEFA for developing broadly protective multivalent vaccines against heterogenous pathogens.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1949-0976
1949-0984
19490976
العلاقة: https://doaj.org/toc/1949-0976Test; https://doaj.org/toc/1949-0984Test
DOI: 10.1080/19490976.2020.1770666
الوصول الحر: https://doaj.org/article/05241bb0c1cd494fbcf414a05e4aa4a0Test
رقم الانضمام: edsdoj.05241bb0c1cd494fbcf414a05e4aa4a0
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:19490976
19490984
DOI:10.1080/19490976.2020.1770666